RI Defeats Hep C
Save The Date
HCV WaterFire
August 1, 2015
Brandon Bruzzi
Receive a Free T-Shirt
When You Donate $30 or More
Help Us Fight Hep C
RI State House in Yellow
RI State House in Yellow
for World Hepatitis Day
Rhode Island
Innovation Fellow
Lynn Taylor
Watch the Video

Hepatitis C The Silent Epidemic

Hepatitis C is a liver disease resulting from chronic infection with the hepatitis C virus (HCV). It is estimated that 5 million Americans are infected with HCV. Because symptoms of HCV infection may not appear for many years, more than 70 percent are unaware they are infected.

C is for CURE – HCV is a curable infection. There are many highly effective pills now available that can cure hepatitis C in most people, most of the time – safely.

The U.S. Centers for Disease Control and Prevention (CDC) now recommends an age-based screening strategy consisting of a one-time screening blood test for HCV for those at highest risk, including people who ever injected drugs (even once many years ago), and everyone born between 1945 and 1965 (“Baby Boomers”). Approximately 75% of HCV infections in the U.S. exist among Baby Boomers. One in 30 Baby Boomers in the U.S. has HCV. This CDC recommendation was endorsed by the U.S. Preventive Services Task Force in June 2013. The broader testing recommendations likely will detect a substantial number of people who are unaware they are infected.

Remember that sharing straws/bills when using cocaine (even once many years ago), and having unprotected anal sex if you are an HIV-infected man who has sex with men, are also risk factors for having HCV. Refer to our selected links for more information on hepatitis C transmission (spread).

Deaths from HCV-related liver disease are on the rise. Early diagnosis allows people who are infected to receive treatment sooner rather than later, and prevent progression to more serious disease, such as cirrhosis (extensive scarring in the liver) and liver cancer.

This video provides a graphic depiction of how to decrease spread of hepatitis C via injection drug use. The video was made by ARUD: https://www.youtube.com/watch?v=Pm5W3T9ODhQ
Here is additional information about ARUD, a model for integrated care: https://www.youtube.com/watch?v=O4zd_hoZPF4

Links Recommended HCV Websites and Reading

There is a lot of misunderstanding about HCV. There is a good deal of misinformation circulating about HCV. If you are looking for more information about HCV, please click on one of the following websites that Dr. Taylor has vetted and supports:

 Relevant Reading

About RI Defeats Hep C

More people are now dying of hepatitis C virus infection (HCV) in the U.S. than are dying of HIV. HCV can cause serious liver disease, including cirrhosis (scarring of the liver) and liver cancer. HCV is the leading cause of liver transplantation in the U.S. Rhode Island Defeats Hepatitis C (RID Hep C) is a project dedicated to the elimination of HCV in Rhode Island (RI).

Supported by an Innovation Fellowship from the RI Foundation to Lynn E. Taylor, MD, RID Hep C is a comprehensive program to Seek, Treat, Cure and Eliminate HCV in RI; reduce illness, suffering and death due to HCV in RI; save money for RI and Rhode Islanders by enhancing proactive HCV care; and bring resources into RI to help combat RI’s HCV epidemic. RID Hep C is designed with several components: Awareness, Testing to Cure, Building Infrastructure for a Sustainable Model, and Evaluation. While there are many steps along the way in HCV infection—prevention, screening, diagnosis, evaluation, treatment, cure, preventing reinfection—what will have the highest impact in the shortest amount of time is to cure as many as possible among those already identified with HCV. Thus we focus on key target populations: Baby Boomers (born 1945-1965) and people with history of injection drug use.

Eliminating HCV in RI requires a coordinated, comprehensive, sustained and multipronged approach. We need to move from single-center, one-approach pilot programs, to developing networks of interventions. RID Hep C key priorities include:

  • Facilitating strategic HCV partnerships in RI
  • Advocating to reduce the stigma and health care disparities associated with HCV
  • Developing efficient, affordable and equitable community-based responses
  • Keeping RI up to date with rapidly evolving best practices for implementing HCV testing, evaluation and curative treatment
  • Improving the capacity of RI’s health systems to address HCV
  • Utilizing innovations in health technology to enhance HCV screening, diagnosis, linkage to care and cure in RI. To this end we aim to have all RI electronic medical record systems include a prompt for one-time HCV screening of baby boomers
  • Developing on-site HCV care for high prevalence populations: at methadone maintenance programs, corrections, HIV care centers and needle exchange programs
  • Fostering HCV research focused on enhancing care in RI
  • Using RI’s world-class arts community to engage people in the HCV field
  • Cultivating the next generation of HCV advocates by bringing HCV to the forefront of education and public health institutions

FREE Hepatitis C Testing at AIDS Care Ocean State (ACOS)

We offer a free and confidential screening test for hepatitis C virus infection (HCV), which look for the presence of HCV antibodies. Antibodies are proteins (a type of chemical) the body makes when exposed to HCV.

A positive or reactive HCV antibody result means that a person has been exposed to HCV. The next best test is a confirmatory HCV RNA by PCR, or HCV viral load – test for the virus itself. If there is HCV virus in the blood (80% of the time), there is a chronic HCV infection. In a fraction of cases (approximately 20% of the time), there is no virus in the blood, meaning that the HCV infection resolved on its own within the first few months after exposure.

The HCV antibody test we use at ACOS is a rapid test, using the Ora-Quick rapid HCV test kit. This test is performed with a finger stick, in which a tiny needle punctures the tip of a person’s finger. Results are ready in 20 minutes.

All staff members performing tests are Qualified Professional Test Counselors certified by the RI Department of Health.

Again to clarify – About 20% of people with positive screening antibody tests clear away the HCV virus on their own within the first few months of infection, without medications. Most people, the other 80%, develop a chronic infection in which HCV viruses are made every day in the liver. People with chronic HCV may go on to develop related health problems. The confirmatory, follow-up blood test is a viral load test called HCV RNA. The HCV RNA viral load test tells if there is HCV in the blood. If the result is reactive, or positive, a person has chronic HCV and will benefit from medical care.

Rapid HCV Testing Hours

  • Monday
    12:00 to 4:00 p.m.
  • Tuesday
    1:00 to 4:00 p.m. & 6:00 to 8:00 p.m.
  • Wednesday
    1:00 to 5:00 p.m.
  • Thursday
    10:00 a.m. to 5:00 p.m. & 6:00 to 8:00 p.m.
  • Friday
    by appointment only

Street Outreach Team

In addition we have a street outreach team that goes into various neighborhoods throughout Rhode Island to offer a wide range of services to the community including HCV testing. Our street outreach team travels in a Big Yellow Van and is able to provide testing and counseling on the spot for anyone interested. You may also contact Raynald Joseph, ACOS Prevention Supervisor: through the contact form below or call AIDS Care Ocean State at (401) 781-0665, to schedule our team to come to your organization or location for testing a group of people.

Who should get tested for HCV?

We have expanded upon the CDC’s list by considering an important article published by HCV expert Brian R. Edlin, MD, of the National Development and Research Institutes, New York, NY. His article is entitled, “Hepatitis C Screening: Getting It Right,” Hepatology. 2013 Apr;57(4):1644-50. Dr. Edlin is also Associate Professor of Public Health and Medicine, Weill Cornell Medical College, and Professor of Medicine, SUNY Downstate College of Medicine, Brooklyn, NY. Dr. Taylor conferred with Dr. Edlin. She then she adapted information from his article for our website. Thank you, Dr. Edlin!

Transmission of HCV occurs via direct blood-to-blood contact -- meaning that blood containing HCV has to get into our body’s bloodstream in order for us to catch HCV. Here is RID Hep C’s list of people we think should get tested for HCV:

  • Persons born from 1945 through 1965.
  • Persons who have ever injected illegal drugs, including those who injected only once many years ago.
  • Persons with a history of intranasal (through the nose, or snorting) drug use, including those who snorted only once many years ago. An example is snorting cocaine.
  • Persons with a history of heavy alcohol consumption.
  • All persons with HIV infection.
  • Persons in correctional institutions and those with a history of incarceration.
  • Persons who received clotting factor concentrates made before 1987.
  • Persons who received a blood transfusion or solid organ transplants before 1992.
  • People who have ever received long-term hemodialysis treatment.
  • Persons with known exposures to HCV, such as:
    • Health care workers after needlesticks involving HCV-infected blood.
    • Recipients of blood or organs from a donor who later tested HCV-positive.
  • Persons with signs or symptoms of liver disease (e.g., abnormal liver enzyme blood tests).
  • Children born to HCV-infected mothers (to avoid detecting maternal antibody -- the adult woman’s positive blood test-- these children should not be tested before age 18 months).
  • Persons with diabetes.
  • Homeless persons and persons with a history of homelessness.
  • Persons with ≥ 10 lifetime sexual partners, and especially those with ≥ 20 lifetime sexual partners.
  • Persons who received unsafe medical injections (steroids, for example) or unsafe tattoos or piercings.
  • Persons born in high-prevalence countries (countries where a large proportion of the population has chronic hepatitis C, such as Egypt).

Ask Your Doctor

During your next primary care appointment, ask your doctor about HCV and how to be screened for HCV. The U.S. Department of Health and Human Services recommends you write down the following questions and take them to your next appointment:

  • Do I need to get tested for the hepatitis C virus (HCV)?
  • How will you test me for hepatitis C?
  • How long will it take to get my test results?
  • How will I find out my test results?
  • If I have hepatitis C, what will happen next?
  • Can you give me some information about hepatitis C to take home with me?

If you do not have a primary care physician, search for one in your area. In RI: www.health.ri.gov/find/primarycare/

Our Progress

Collaboration with the non-profit organization CODAC Behavioral Healthcare

The RI Defeats Hep C Innovation Fellowship facilitated Dr. Taylor’s and ACOS’ collaboration with the non-profit organization CODAC Behavioral Healthcare, www.codacinc.org. As a result, the Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, awarded a grant to CODAC which started July 1, 2013, to enhance HCV Screening, Referral, Treatment and Cure.


The purpose of this program is to address the high prevalence of HCV among people who inject drugs or injected drugs in the past in selected opioid treatment programs. Dr. Taylor serves as Consulting Physician. In Spring 2014, Dr. Taylor started on-site hepatitis C care at CODAC Huntington Ave.

RID Hep C is on Target

From August 2013-January 2014, we had a 13% positivity rate on our HCV antibody screenings (versus estimated 1.3% of the U.S. population overall). Of these, 84% had detectable HCV RNA, indicating that RID Hep C’s testing was on target.

We Have RI Students Joining Our Efforts

Aaron Shapiro

Aaron Shapiro is a medical student at the Alpert Medical School of Brown University ('18). He works with Dr. Lynn Taylor in developing on-site hepatitis C care integrated with treatment for addiction. He is a National Health Service Corps Scholar and a participant of the Infectious Disease Society of America Medical Scholars Program. Aaron is a Global Health Corps Fellow ('11) with a BS in Global Health from the University of Maryland, College Park.


Naomi Adjei

Naomi Adjei is a medical student at the Warren Alpert Medical School of Brown University (‘17). Naomi worked with Dr. Taylor to organize the first and second, C IS FOR CURE: A WATERFIRE LIGHTING FOR RI DEFEATS HEP C, IN HONOR OF WORLD HEPATITIS DAY -- July 26, 2014 and August 1, 2015


Soumitri Barua

Soumitri Barua is a Brown University undergraduate in the Program in Liberal Medical Education (’17, MD’21) and concentrating in Public Health. She worked with Dr. Taylor to determine state by state Medicaid reimbursement of sofosbuvir for the treatment of HCV. Results of this research were published June 2015 in Annals of Internal Medicine. Soumitri works with Dr. Taylor to enhance HCV screening of RI baby boomers.


Aaron Kofman

Aaron Kofman is a resident physician in Internal Medicine at the University of California, San Diego. Previously a medical student at Brown University, he worked for 3 years with Dr. Taylor helping to care for patients with HCV and HIV. When working with RID Hep C, Aaron helped patients dually infected with HCV and HIV obtain access to clinical trials; worked on developing an electronic medical screening for HCV in RI Baby Boomers; and profiled the work of ENCORE, Rhode Island's only Needle Exchange Program at AIDS Care Ocean State.


Ali Zaman

Ali Zaman worked with RID Hep C to help expand capacity for HCV treatment for opiate-dependent patients.


Burke Gao

Burke Gao worked with Omar Galarraga, PhD and RID Hep C to model the costs of HCV treatment for RI's HCV population, and compared those investments with the resources saved from avoiding HCV-related complications.


Lizzy Kinnard

Lizzy Kinnard worked with Brandon Marshall, PhD, and Dr. Taylor to estimate the true prevalence of HCV in RI. This research was published in Rhode Island Medical Journal's special July 2014 edition on HCV.

Scaling Up Hepatitis C Screening in the United States

On September 17 and 18, 2013, our first Hepatitis C Navigator, Elier Reyes, served as a panelist at Project Inform’s HCV Think Tank Meeting, “Scaling-Up Risk-Based Hepatitis C Screening in the United States.” Hosting 30 national, state and local health officials, policy experts, doctors and community advocates, Project Inform will utilize the Think Tank to discuss the state of risk-based HCV screening, its challenges and successes, and ways to leverage the Affordable Care Act to improve access to testing, increase status awareness and decrease health disparities. Elier was on a panel with national HCV leaders, include those from the CDC and experts on clinical care and health systems. Eli presented a Community Based Organization Perspective.


Elier’s participation gave our Rhode Island communities a voice in this national discussion, and provided an opportunity for him to gather information that will be helpful to RIDHepC.

RI Defeats Hep C: Hep C 101 -- Current Standard of Screening, Diagnosis and Treatment for HCV Testers

We are working to expand the number of HCV screeners/testers in RI, to enhance our capacity to get at-risk persons screened. To this end, in Fall 2013, we held a, “RI Defeats Hep C: Hep C 101 -- Current Standard of Screening, Diagnosis and Treatment for HCV Testers,” educational session for community partners. RID Hep C also assists in Hepatitis C Testing and Counselling courses for Health Professionals.

RID Hep C is assisting our state in developing a Hepatitis C Strategic Plan for RI…
Stay tuned!

RID Hep C Special HCV Edition of the Rhode Island Medical Journal

 

Events

Therapy for Chronic Hepatitis C in 2014

First annual Dennis Mikolich Lecture:
"Therapy for Chronic Hepatitis C in 2014"

Invited speaker: Dr. Norbert Brau
Professor of Medicine, Divisions of Infectious Diseases and Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY
Medical Director, Viral Hepatitis Program, Bronx VA Medical Center

April 4, Friday at Noon: 5th Floor Classroom 3 at the Providence VAMC

Rectangle logo with text, 'Hepatitis Awareness Month'

Treating and Defeating Hep C in Rhode Island

The month of May is designated as Hepatitis Awareness Month in the United States. In honor of Viral Hepatitis Month, RID Hep C sponsored an Educational Conference with the Warren Alpert Medical School of Brown University on May 16, 2014, entitled, “Treating and Defeating Hep C in Rhode Island.” The Conference was held at The Omni Providence Hotel | Providence, RI.

Target Audience

This educational conference was designed for physicians and other health care practitioners (nurse practitioners and other nursing professionals, physician assistants, pharmacists, psychologists, social workers) who are involved (or soon to be involved) in the diagnosis and management of patients with HCV infection. This conference was particularly relevant for practitioners in the fields of gastroenterology, hepatology, infectious diseases, HIV, corrections, internal medicine, family medicine, psychiatry and public health.

This activity has been approved for AMA PRA Category 1 Credits™

Conference Brochure

Conference Student Abstract Competition Winners

  • 1st Place: John T. Nguyen
John T. Nguyen Poster Design
John T. Nguyen

John T. Nguyen MPH’s, poster submission for the Treating and Defeating Hep C in RI Educational Conference was adapted from his thesis work with Drs. Brian Montague and Josiah Rich. John worked with the RI Department of Corrections (RIDOC) HCV Committee to utilize the electronic medical records system for improved HCV tracking and management. He also developed budgetary prediction models for comparative analysis of newly approved and upcoming HCV therapies as they pertained to RIDOC's efforts to provide HCV treatment and care in corrections.

Elizabeth Kinnard Poster Design

Conference Contributors

Nicole Alexander-Scott, MD, MPH
Nicole Alexander-Scott, MD, MPH
Rachel Baden, MD
Rachel Baden, MD
Jeffrey Bratberg, Pharm D, BCPS
Jeffrey Bratberg, Pharm D, BCPS
Brian R. Edlin, MD
Brian R. Edlin, MD
Nkiruka Emeagwali MD, PhD, MS
Nkiruka Emeagwali, MD, PhD, MS
Camilla Graham, MD MPH
Camilla Graham, MD, MPH
Arthur Y. Kim, MD
Arthur Y. Kim, MD
Alain H. Litwin, MD, MPH
Alain H. Litwin, MD, MPH
Brandon DL Marshall, PhD
Brandon DL Marshall, PhD
Kittichai Promrat, MD
Kittichai Promrat, MD
Thomas E. Sepe, MD
Thomas E. Sepe, MD
Anne Spaulding, MD, MPH
Anne Spaulding, MD, MPH
John B. Wong, MD
John B. Wong, MD
Paul G. Loberti, MPH and Paul Fitzgerald, MSW
Paul G. Loberti, MPH and Paul Fitzgerald, MSW
Michaela Maynard, MPH and Lynn E. Taylor, MD
Michaela Maynard, MPH and Lynn E. Taylor, MD
Drs. Sepe, Graham, Bratberg, Marshall, Wong, Edlin
Drs. Sepe, Graham, Bratberg, Marshall

Hepatitis C: C is for Cure

RI EOHHS Monthly Educational Talkbacks Presents:
Hepatitis C: C is for Cure featuring Lynn E. Taylor, M.D.

This program was held on Monday, May 19th, 2014 at 4:00 PM at the Rochambeau Library located at 708 Hope St. in Providence. The keynote speaker was Lynn E. Taylor, M.D. who is an HIV specialist focusing on HIV and Viral hepatitis coinfection (infection with both HIV and viral hepatitis).

Sponsored by the Executive Office of Health and Human Services. Ryan White Program

RI Defeats Hep C Poster Design Competition Results

  • 1st Place: Hayward H Gatch IV
Hayward H Gatch IV Poster Design
  •  
  • 2nd Place: Brandon Bruzzi
Brandon Bruzzi Poster Design

Event photographs by Brian DeMello
See the Photos

C is for Cure: A WaterFire Lighting for RI Defeats Hep C, in honor of World Hepatitis Day

  • July 26, 2014

C is for Cure: A WaterFire Lighting for RI Defeats Hep C www.waterfire.org, was held on July 26, 2014, in honor of World Hepatitis Day. According to WaterFire’s Fall 2014 newsletter SPARKS, the event drew 65,000 attendees. The event was held to raise awareness; build Community, Connection, Cooperation, Camaraderie; help diminish stigma; inspire people to get tested and cured; and create a beautiful, family-oriented, artistic, musical, creative, enchanting, free summer night out on the town. Our event included entertainers, food, music, education, and testing.

RID Hep C was privileged to welcome Scott Holmberg, MD, MPH, to kick off our July 26, 2014 -C is for Cure: Waterfire Lighting

We are honored to have Dr. Holmberg again lead the torch lighting for this year’s WaterFire, August 1, 2015.

Dr. Scott Holmberg

Dr. Scott Holmberg is the Chief of the Epidemiology and Surveillance Branch, Division of Viral Hepatitis, U.S. Centers for Disease Control and Prevention (CDC). His unit is responsible for national surveillance for and outbreak investigations of hepatitis A,B,C,D and E. Dr. Holmberg is a leader in the CDC’s focus on hepatitis C in the U.S. He works to improve opportunities to improve identification and care of people with hepatitis C and decrease hospitalizations and deaths resulting from hepatitis C (Holmberg SD, et al. Hepatitis C in the United States. N Engl J Med. 2013 May 16;368(20):1859-61). Dr. Holmberg was the first to present CDC findings that there are more Americans dying now from hepatitis C than from HIV/AIDS.

 

Current projects include the Chronic Hepatitis Cohort Study involving thousands of hepatitis B and C patients; analysis of ‘NHANES’ data from >5,000 randomly selected households/year in the U.S.; and analyses of several large national datasets related to hepatitis morbidity and mortality. Dr. Holmberg’s work with outbreaks started as a Peace Corps Volunteer in Ethiopia (1971-73) in the World Health Organization (WHO) Smallpox Eradication Programme, after undergraduate studies at Harvard. Thereafter, he attended Columbia University’s College of Physicians and Surgeons (1975-9), trained in internal medicine at RI’s own Roger Williams Hospital, Providence (1979-82), and CDC’s Epidemic Intelligence Service (1982-85). For 19 years (1986 – 2005), Dr. Holmberg was Chief of the Clinical Epidemiology Section in CDC’s Division of HIV/AIDS Prevention, where he started and supervised many large studies of H IV/AIDS. Dr. Holmberg has authored or co-authored over 230 medical journal articles and is the recipient of several high US Public Health Service and CDC awards.

  •  
  • Rhode Island Medical Journal: One WaterFire Torch, One Life Remembered
  •  
  • WaterFire Providence | Dr. Lynn Taylor on C is for Cure

    July 26th, 2014, WaterFire Providence and RI Defeats Hep C partnered to create the "C is for Cure" hepatitis C awareness event. Dr. Lynn Taylor, director of RI Defeats Hep C, speaks about the Rhode Island Foundation Innovation Fellowship, developing the C is for Cure WaterFire event, and the outcome she and her organization experienced by partnering with WaterFire Providence.

Restricting Access to New Treatments for Hepatitis C Virus Among People Who Use Drugs: Is this ethical or justifiable based on the available data?

  • Wednesday, November 12th 2014

This lecture was given by Jason Grebely, PhD, a global leader in the field of HCV epidemiology. Areas of expertise include: impact of HCV treatment on population mortality; role of opiate replacement therapy in the treatment of HCV; acute HCV; feasibility and benefits of HCV elimination; treatment of HCV in people who inject drugs; HIV/HCV coinfection; and HCV treatment as prevention. Dr. Grebely is a driving force of the International Network on Hepatitis in Substance Users (INHSU), and spearheaded the INHSU’s CID 2013 supplement, “Moving the Agenda Forward: the Prevention and Management of HCV among People who Inject Drugs.” Dr. Grebely received his PhD from the University of British Columbia in Vancouver, Canada and currently works at the University of New South Wales in Sydney Australia.

May is Hepatitis Awareness Month.
What is happening in Rhode Island?

  • May 10-13, 2015

The Caring Ambassadors Program, an organization designed to help improve the lives of those affected by challenging health conditions through advocacy, information, and support, is hosting an Advocates Unite! Conference, May 10-13 2015, in Washington, D.C. Caring Ambassadors sponsors two delegates from each state in the U.S. to attend the conference. The focus is on teaching people how to become successful advocates for hepatitis C policy change. Congratulations to our Rhode Island delegates, Paul Kelly and Brad Brockmann.

Paul Kelly is a local advocate for hepatitis C awareness. Stemming from his personal experiences with the disease, Paul is committed to letting the world know that hepatitis C is a silent epidemic that needs to be better addressed.

For information about Brad Brockmann please go to the, “Our Team” section.

Transforming Care in Hepatitis C

  • July 28, 2015

Camilla S. Graham, MD, MPH, Assistant Professor in Medicine, Harvard Medical School; Medical Staff, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA will be giving Medicine Grand Rounds on hepatitis C. The session will provide information on: strategies to diagnose patients with hepatitis C infection and provide initial care; antiviral treatment choices for hepatitis C; barriers to hepatitis C treatment access and how to work with payers.

C is for Cure: A WaterFire Lighting for RI Defeats Hep C, In Honor of World Hepatitis Day

  • Saturday, August 1, 2015

RID Hep C’s second “C is for Cure: A WaterFire Lighting for RI Defeats Hep C” will be held on Saturday, August 1, 2015, in honor of World Hepatitis Day. The purpose of this event is to raise awareness; build Community, Connection, Cooperation, Camaraderie; help diminish stigma; inspire people to get tested and cured; and have a beautiful, family-oriented, artistic, musical, creative, enchanting, free summer night in beautiful downtown Providence. Our WaterFire will include entertainers, food, music, education, and free, confidential Hep C testing. Let’s put HCV on the map in RI, the U.S. and beyond!

WaterFire Providence is an independent, non-profit arts organization whose mission is to inspire its visitors by revitalizing the urban experience, fostering community engagement and creatively transforming the city by presenting WaterFire for all to enjoy. WaterFire centers around the installation of 80 bonfires floating on Providence’s 3 rivers. It attracts a large (about 65,000 people for each WaterFire event), diverse group of visitors (over 50% from out of state) and draws a strong international crowd. Recently, WaterFire has expanded with fires in Ohio, Missouri, Texas, Pennsylvania and with unique lightings in Singapore and Rome.

Meet The Team

Lynn E. Taylor
Lynn E. Taylor, MD Director
In May 2013, Lynn E. Taylor was awarded a Rhode Island Innovation Fellowship entitled, "Rhode Island Defeats Hep C.” She is a viral hepatitis, HIV/AIDS and primary care physician focusing on prevention and treatment of HCV and hepatitis B viruses in vulnerable populations and on the primary care of people living with HIV. She developed and directs Miriam Hospital's HIV/Viral Hepatitis Coinfection Program. Her research, patient care, teaching and community-based efforts involve extending HCV care to persons with HIV and co-existing substance disorders, and improving HCV screening, diagnosis and treatment uptake.
Paul Fitzgerald
Paul Fitzgerald
Paul Fitzgerald MSW is the Executive Director/CEO of AIDS Care Ocean State.  Paul founded the Family AIDS Center for Treatment (FACTS) in 1987 to address mother to child transmission of HIV. He worked tirelessly with community members to establish housing, preventative care, and counseling to families affected by HIV/AIDS.  Paul has always been a huge advocate and supporter of the HCV community.  He helped start Rhode Island’s first free confidential, fully integrated HIV and HCV testing site.  The goals were to increase awareness throughout the community, increase access to testing, and make referrals to care as seamless as possible. Paul Fitzgerald has been a guiding light for the community and continues to lead his organization on the bright path.
Raynald Joseph
Raynald Joseph ACOS Prevention Supervisor
Raynald Joseph has been the Prevention Supervisor for AIDS Care Ocean State (ACOS) for 4 years. As the Prevention Supervisor he oversees all things prevention, including the Street Outreach program, ENCORE (RI’s only Needle Exchange Program), and HIV and HCV testing. Raynald is passionate about the work he does. He loves the opportunity to connect with clients and link them to the care and services they need.
ACOS Prevention Center Website
Osvaldo Lugo
Osvaldo Lugo ACOS Prevention Specialist/Outreach Coordinator
Osvaldo Lugo has been the Prevention Specialist/Outreach Coordinator for AIDS Care Ocean State (ACOS) for 3 years. As the Prevention Specialist/Outreach Coordinator, Osvaldo is the key person for all off-site testing. Osvaldo organizes and runs all special testing events. He also organizes and runs the Street Outreach program, setting up a schedule which includes venue locations and times for the street outreach workers.
Melissa Hordes
Melissa Hordes Hepatitis C Project Navigator
Melissa Hordes is the Hepatitis C Project Navigator for Rhode Island Defeats Hep C. Her role is to assist Lynn Taylor in facilitating RID Hep C’s key priorities. While completing her B.S. in public health at Syracuse University, Melissa focused her work on substance use disorders and harm reduction strategies.
Brandon Marshall
Brandon Marshall, Ph.D. Mathematical Modeler
Dr. Marshall's research interests focus on substance use epidemiology and the social, environmental, and structural determinants of health of urban populations. In particular, his work seeks to inform public health and policy interventions that improve the health of drug users. With RI Defeats Hep C, he will be applying mathematical modeling tools to determine the most effective way to prevent, treat, and defeat hepatitis C in Rhode Island.
Learn More…
Omar Galárraga
Omar Galárraga, Ph.D. Economist
Omar Galárraga, Ph.D. is an Assistant Professor at Brown University, School of Public Health (Department of Health Services, Policy & Practice) where he teaches and conducts research on economic aspects of prevention and treatment of HIV and other sexually transmitted infections, including economic incentives interventions. His research appears in health economics and public health journals. His teaching includes topics on HIV/AIDS disparities, large dataset statistical analysis, and global health economics. His role in Rhode Island Defeats Hep C will include modeling the economic impact of the proposed interventions including potential cost-effectiveness and cost-savings at the state level.
Learn More…
Keith McManus
Keith McManus Video Producer
Keith McManus is a Rhode Island based video producer that has spent 25 years working in broadcast television and multimedia production. His experience includes a multitude of skills that made him the perfect collaborated to distill and present the issues of Hep C to public. He has a passion for story telling, social justice, and bringing about positive change in the world. His 2 minute video was the essential link in winning the RI Foundation Fellowship Grant that launched our efforts.
Megan
Megan Pinkston-Camp, M.A., Ph.D. Consulting Psychologist
Megan Pinkston-Camp, M.A., Ph.D. is a clinical health psychologist who provides evidence-based treatments to persons with HCV and HIV. She works with patients before and during their course of HCV treatment by providing care for mental health and/or substance use concerns to facilitate HCV treatment initiation and completion. She runs a support group for people living with both HIV and HCV. Dr. Pinkston has extensive training and experience in the fields of addiction, mental health, HIV and HCV. For RI Defeats Hep C, Dr. Pinkston-Camp will work with Dr. Taylor to develop innovative group HCV treatment models to expand Rhode Island’s capacity to treat more people for HCV.
Jeffrey Bratberg
Jeffrey Bratberg, PharmD Collaborating Pharmacist
Dr. Bratberg collaborates with physicians on infectious diseases patient consultations at Roger Williams Medical Center and teaches in and coordinates all of the infectious diseases courses at the University of Rhode Island (URI) College of Pharmacy. His research interests include expanding pharmacists’ roles in public health, particularly in HIV/HCV, prevention of opioid drug overdose and death, and expanding immunization practices. Jeffrey is an immunization, drug overdose prevention and emergency preparedness consultant to the Rhode Island Department of Health. Dr. Taylor's invited lecture on viral hepatitis to PharmD students at URI has been a highlight of the infectious diseases core curriculum for several years. This fruitful collaboration continues with Dr. Bratberg's work on RI Defeats Hep C to develop, review, and maintain HCV treatment protocols for HCV treating physicians in RI.
Brad Brockmann
Brad Brockmann Consultant & Liaison
Brad Brockmann is the first Executive Director of the Center for Prisoner Health and Human Rights in Providence. The Center seeks to advance the health and human rights of prisoners and other criminal justice populations through education, research, and advocacy. Brad is a civil rights litigator who has been advocating on behalf of prisoners for over a decade. For RI Defeats HepC, he will recruit and oversee college students working on the project, consult on healthcare reform issues, and serve as liaison to the Department of Corrections to develop a health education campaign at the state prison and in probation/parole.
Jules Levin
Jules Levin Inspiration
Jules Levin spearheaded New York City (NYC)’s HCV demonstration project and raised millions of dollars in private funding to do so. He is the founder and Executive Director of the National AIDS Treatment Advocacy Project (NATAP), an internet resource for global HIV and hepatitis conference coverage and scientific information. NATAP has been a leader in HCV education and information and in policy/advocacy since 1995. Over 17,000 individuals have attended NATAP events. As an advocate and activist, Mr. Levin has put HCV and HIV/HCV coinfection on the map; Mr. Levin has been a leader in the in NYC, NY state and federal HIV and viral hepatitis advocacy communities since the early 1990s, with numerous achievements that have changed the course of hepatitis-related policy and service delivery across the nation. Jules Levin lives with HIV and was coinfected with HCV for 30 years prior to being successfully treated and cured of HCV.
Boris Bally
Boris Bally Artistic Consultant & Advisor
Artistic Consultant and Advisor to the project, Bally maintains a thriving art/metals/design studio in Providence. He is the recipient of the 2006 Individual Achievement Award for Visual Arts presented by the Arts & Business Council of Rhode Island. His work has received two Rhode Island Council on the Arts Fellowships in Design and a Pennsylvania Council on the Arts Crafts Fellowship. Bally’s work is featured in numerous international exhibitions and publications. Public collections include London’s V&A Museum, Museum of Art & Design New York, Carnegie Museum of Art Pittsburgh, Brooklyn Museum, Renwick Gallery and Cooper Hewitt National Design Museum. An example of his anti-gun violence work in Rhode Island may be seen across from the Courthouse on North Main Street.
Shepard Fairey
Shepard Fairey Juror
World-renowned RI artist Shepard Fairey will be the Juror for RI Defeats Hep C’s Poster Competition.  Fairey is a contemporary artist and designer. He is also the person behind OBEY GIANT, graphics he started when he was a RISD student.  These graphics have changed the way people see art and the urban landscape, and have evolved into a worldwide street art campaign and a body of fine art.  Fairey's art reached widespread acclaim in 2008, when his "HOPE" portrait of Barack Obama became the image of the presidential campaign. The original image now hangs in the Smithsonian Institution in Washington, D.C.  The posters selected by Fairey will win an award and will be used in state-wide hepatitis C awareness efforts.

Press What people are saying…

Brown University

Undergrad’s Study Questions States’ Hep C Policies

  • June 30, 2015
  • By David Orenstein

Though she’s just 19, rising public health junior Soumitri Barua is the lead author of a study showing that most states in 2013 were rationing hepatitis C treatment against the recommendations of doctors and possibly against federal law. Dr. Lynn E. Taylor, her mentor, calls her efforts “stellar.”…

Read More
American College of Physicians

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

  • July 10, 2015

Author, Lynn E. Taylor, MD, calls Medicaid restrictions on sofosbuvir for the treatment of hepatitis C virus a violation of human rights. She and her colleagues discuss her recent paper in Annals.

Watch Now
Annals of Internal Medicine

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

  • June 30, 2015

The aim of this study was to systematically evaluate state Medicaid policies for the treatment of hepatitis C virus (HCV) infection with sofosbuvir in the United States. Medicaid reimbursement criteria for sofosbuvir were evaluated in all 50 states…

Read More
EurekAlert

National study finds life-threatening barriers in access to breakthrough drugs

  • June 29, 2015

PROVIDENCE, R.I. - Most states violate federal Medicaid law because they deny coverage for sofosbuvir, a new and highly effective treatment to cure hepatitis C, according to Lynn E. Taylor, M.D., director of The Miriam Hospital's HIV/Viral Hepatitis Coinfection Program…

Read More
Medical Xpress

National study finds life-threatening barriers in access to breakthrough drugs

  • June 29, 2015

Hepatitis C virus affects over three million Americans. Worldwide, an estimated 120 to 150 million people have chronic hepatitis C. Left untreated, the infection can lead to cirrhosis, liver failure, and liver cancer…

Read More
Convergence RI

Singing the Hep C blues on RIPR

  • January 19, 2015
  • By Richard Asinof

PROVIDENCE – For an hour on live radio, a panel of experts politely shared their anger and outrage about the Hepatitis C epidemic in Rhode Island, their cogent words spoken mostly in the even-keel, modulated tones appropriate for an NPR public forum, before a sparse audience of about 70…

Read More
Rhode Island Public Radio

At The Crossroads, Part 6: Veterans Harder Hit By Hep C

  • December 5, 2014
  • By Kristin Gourlay

In our ongoing series about hepatitis C, we look now at one of the hardest hit populations: veterans. Hep C is three times more prevalent among vets than in the general population. The Veterans Health Administration has the country’s largest hepatitis C screening and treatment program in the country…

Read More
The Brown Daily Herald

R.I. Medicaid limits supply of Hepatitis C drug due to cost

  • December 4, 2014
  • By Emma Jerzyk

Rhode Island’s Medicaid program decided in September to ration the delivery of Sovaldi, a prescription drug approved by the U.S. Food and Drug Administration last year to cure chronic Hepatitis C, due to the drug’s high cost and the relatively high prevalence of the virus among Medicaid enrollees in the state…

Read More
Rhode Island Public Radio

At The Crossroads, Part 5: The Uncomfortable Math Of Hep C Treatment

  • November 26, 2014
  • By Kristin Gourlay

What’s the price of a human life? Many of us would say each life is priceless. But health economists sometimes have a number in mind.

Want to know what that number is?

In this part of our series “At the Crossroads: The Rise of Hepatitis C and The Fight To Stop It,” we'll tell you that - and more…

Read More
Rhode Island Public Radio

At The Crossroads, Part 4: New Hep C Drugs Promise A Cure, For A Big Price

  • November 20, 2014
  • By Kristin Gourlay

This year marks the 25th anniversary of the discovery of the hepatitis C virus. Since then, people with hepatitis C have had limited – and not very effective – options for treatment.

Until now.

Revolutionary new treatments have hit the market in just the last few months…

Read More
Pittmed

Let's Eliminate Hep C
Spotlight: Lynn E. Taylor

  • Fall 2014
  • By Elaine Vitone

The ever-widening epidemic of hepatitis C virus—the leading cause of liver transplants in the United States—has long been ignored and neglected, says Lynn E. Taylor (MD ’97), assistant professor of medicine at Brown. This is partly because of its stigma, and partly because the real weight of it is just beginning to hit…

Read More
Sparks

WaterFire Helping RI Defeat Hep C

Dr. Lynn E. Taylor Partners with WaterFire to Help Eradicate hepatitis C in Rhode Island

  • Fall 2014

On Sat., July 26th, 65,000 people gathered to watch the ring of fire and ensuing ceremony as 100 physicians and persons at the forefront of the fight to eradicate hepatitis C in Rhode Island encircled Waterplace Park basin with torches alite…

Read More
Rhode Island Public Radio

At The Crossroads, Part 3: As Old Hepatitis C Treatment Fades Out, New Treatments Stoke Hope

  • November 12, 2014
  • By Kristin Gourlay

In just a few weeks, another pharmaceutical company will likely win FDA approval for a new drug to cure hepatitis C. That makes three breakthrough medications hitting the market in less than a year. It’s big news for the estimated twenty thousand Rhode Islanders…

Read More
Rhode Island Public Radio

At The Crossroads, Part 2: Finding Hep C Infections Before It's Too Late

  • November 3, 2014
  • By Kristin Gourlay

Hepatitis C infects an estimated five million Americans, nearly 20-thousand Rhode Islanders among them. And most of them don’t know it. But many are about to find out. It takes about 20 years for most people to notice any symptoms from hepatitis C, and it was about that long ago most people got infected…

Read More
Rhode Island Public Radio

At The Crossroads, Part 1: A Tale Of Two Epidemics

  • October 21, 2014
  • By Kristin Gourlay

One infectious disease – Ebola – is dominating the headlines now. But there’s another that affects far more people around the world, including here in the U.S.

Hepatitis C infects an estimated five million Americans, though most of them don’t know it, because it takes years for symptoms to emerge…

Read More
Brown Medicine

Front and Center
Lynn Taylor moves hepatitis C from the sidelines to the mainstream.

  • Fall 2014
  • By Kris Cambra

At the bus stop, in the supermarket, on the playground, strangers whisper their closely held secrets to Lynn E. Taylor, MD RES’00 F’05: “My husband has hepatitis C. My sister died of it. I have it.”

These impromptu confessions do more than illustrate the stigma that still surrounds the virus. They prove that Taylor has become a powerful voice for awareness, screening, and treatment in Rhode Island…

Read More
Providence Business News

Five Questions With: Dr. Lynn Taylor

  • September 1, 2014
  • By Harold Ambler

PBN: Are people reluctant to participate in hepatitis C screenings? If so, why are they reluctant?

TAYLOR: As we address hepatitis C in a more comprehensive way, we need to consider barriers at the patient level, physician level, and systems level. I do not think that people are reluctant to be screened for hepatitis C once they are made aware…

Read More
Rhode Island Public Radio

On World Hepatitis Day, An Invitation

  • July 28, 2014
  • By Kristin Gourlay

Baby boomers are five times as likely to have chronic hepatitis C as any other age group. That's why the CDC launched a public health campaign to encourage boomers to get screened for the disease. And so, in honor of World Hepatitis Day, I invite---no, I encourage--boomers to get tested for hepatitis C…

Read More
WPRO

Dr. Lynn Taylor - hepatitis C

  • July 26, 2014
  • By Steve Klamkin

PODCAST: Learn about Dr. Lynn Taylor's effort to eliminate hepatitis C in Rhode Island.

Listen Now
abc6.com

WaterFire to help raise awareness of hepatitis C

  • July 25, 2014
  • By The Associated Press

PROVIDENCE, R.I. (AP) _ This weekend's WaterFire will feature free hepatitis screenings to help raise awareness of a virus that affects an estimated 17,000 Rhode Islanders…

Read More
WPRI.com

WaterFire lights flame for those affected by Hep C

  • July 25, 2014
  • By Macey Farnsworth with Angie Angers

Providence is suiting up to recognize the millions of Americans living with Hepatitis C this Saturday at WaterFire.

Sponsored by Gilead, a company who aids those living with life threatening diseases, C is for Cure: A WaterFire Lighting for RI Defeats Hep C will kick off this Saturday night…

Read More
The Rhode Island Foundation

Hep C taking spotlight at Waterfire

  • July 25, 2014
  • By Chris Barnett

A statewide campaign to eliminate hepatitis C in Rhode Island will offer people free, confidential screenings at Waterfire this Saturday beginning at 6 p.m. on the College Street Bridge…

Read More
Rhode Island Public Radio

WaterFire Lighting Spotlights Hepatitis C

  • July 25, 2014
  • By Kristin Gourlay

This Saturday, WaterFire Providence is dedicated to raising awareness about hepatitis C. Organizers are offering free hepatitis C screenings at the event.

WaterFire volunteers will light more than eighty bonfires along the downtown river on Saturday night. A group called Rhode Island Defeats Hep C, led by Dr. Lynn Taylor, organized the lighting…

Read More
Providence Journal

RI boomers urged to get screened for hepatitis C

  • July 24, 2014
  • By Thomas J. Morgan

PROVIDENCE — The dome of the State House will glow yellow starting Saturday in recognition of a “silent epidemic” of hepatitis C, only recently recognized, that is sweeping through America’s baby boomers…

Read More
HIVandHepatitus.com

Medicare Will Cover Hepatitis C Screening for Baby Boomers and People at Risk

  • June 4, 2014

The Centers for Medicare and Medicaid Services (CMS) announced this week that Medicare will cover hepatitis C virus (HCV) screening for adults born between 1945 and 1965, as well as others considered at risk…

Read More
The Miriam Hospital

Miriam Hospital physician advocates awareness and collaboration to combat peaking hepatitis C epidemic

  • July 2014

PROVIDENCE, R.I. – Lynn E. Taylor, M.D., director of The Miriam Hospital’s HIV/Viral Hepatitis Coinfection program, states in the July, 2014 Rhode Island Medical Journal special edition, “RI Defeats Hep C” that eliminating hepatitis c virus infection (hep c or HCV) is feasible…

Read More
WaterFire Providence

WaterFire Announces Details Of Next Full Lighting On Saturday, July 26

  • July 17, 2014

WaterFire Providence, the award-winning sculpture by artist Barnaby Evans, announces the details of the next full lighting of the 2014 season, Saturday, July 26th. This lighting is sponsored by Gilead Sciences, Inc…

Read More
World Health Organization

Partners sign call to action on hepatitis

  • June 5, 2014

Participants of the first global partners' meeting on hepatitis convened by WHO in March 2014 agree on a historic "Call to action to scale up global hepatitis response"…

Read More
NIDA Insite

Dr. Jag Khalsa
May 2014’s Who’s Who at NIDA

  • May 2014

May 2014’s Who’s Who at NIDA features Dr. Jag Khalsa, Chief, Medical Consequences Branch, Division of Pharmacotherapies and Medical Consequences of Drug Abuse, NIDA, champion of research on addiction and its medical consequences of HCV and HIV…

Read More
Rhode Island Medical Women's Association

Lynn E. Taylor, MD, FACP
2014 Woman Physician of the Year

  • April 16, 2014

Lynn E. Taylor, MD, FACP will be honored as the 2014 Rhode Island Medical Women’s Association (RIMWA) Physician of the Year at its annual meeting and dinner on Tuesday, May 13 at the Providence Marriott…

Read More
Johnson & Wales University

Hayward Gatch IV ’14 placed first in RI Defeats HepC Poster Design Competition

  • Winter 2014

RI DEFEATS HEP C (ridefeatshepc.com) recently announced that student Hayward Gatch IV ’14 placed first in its HepC Poster Design Competition…

Read More
AIDS Care Ocean State

"C"is for CURE

  • September 2013
  • By Kalene Brennan

Earlier this year, the Rhode Island Foundation announced their 2013 Innovation Fellows. Out of a pool of 180 original proposals, AIDSCare Ocean State's Medical Director, Dr. Lynn E. Taylor…

Read More
RIMED

Dr. Lynn Taylor Joins International Colleagues in Calling for Better Management of Hepatitis C Among Drug Users

  • August 2013

A Miriam Hospital researcher has joined forces with international colleagues to call for new strategies to better manage and improve assessment and treatment for hepatitis C…

Read More

RI Innovation Fellowship winners chosen

  • April 30, 2013
  • WPRI

An interview with Rhode Island Fellowship winners Lynn Taylor and Adrienne Gagnon on The Rhode Show…

Watch Now

R.I. Foundation awards two innovation fellowships

  • April 25, 2013
  • By Mariya Bashkatova

Lynn Taylor, assistant professor of medicine at Alpert Medical School and attending physician at Miriam Hospital, and Adrienne Gagnon, executive director and co-founder of Downcity Design, were each awarded a three-year Rhode Island Innovation Fellowship to fund their efforts…

Read More
The Miriam Hospital

Lynn E. Taylor, MD, Receives Prestigious 2013 Rhode Island Foundation Innovation Fellowship

  • April 18, 2013

Lynn E. Taylor, MD, an HIV and viral hepatitis specialist, primary care physician and director of the HIV/Viral Hepatitis Coinfection Program at The Miriam Hospital, is one of two recipients of the 2013 Rhode Island Innovation Fellowship…

Read More

2013 Rhode Island Innovation Fellows to focus on 'design thinking' and eradication of Hepatitis C

  • April 16, 2013

From a pool of 180 applicants, Adrienne Gagnon and Lynn Taylor have been selected as 2013 Rhode Island Innovation Fellows. Congratulations, Lynn and Adrienne!

Read More

Many Thanks…

  • Renso Acevedo
  • Rob Adamoski
  • Naomi Adjei
  • Nicole Alexander-Scott
  • Ijeoma Azodo
  • Alex Bally
  • Boris Bally
  • Doris Bally
  • Corinne Barber
  • Soumitri Barua
  • Judy Bentkover
  • Alix Bernardo
  • Tom Bertrand
  • Donna Blais
  • Tim Blankenship
  • Christopher Botelho
  • Samantha Bowen
  • Norbert Bräu
  • Bradford Briggs
  • Brad Brockmann
  • Dolores Brooks
  • Peggy Brown
  • Brown University Alpert Medical School
  • Brandon Bruzzi
  • Mike Bryce
  • Maria Burgo
  • Treniece Cady
  • Ali Caine
  • Marlene Callahan
  • Kris Cambra
  • Charles CJ Carpenter
  • Ken Carpenter
  • Jane Carter
  • Beverly Case
  • Phil Chan
  • Kim Chapin
  • Sandra Cheng
  • Sapna Chowdhry
  • Jamie Comella
  • Bronwyn Dannenfelser
  • Theresa Desautels
  • Tyler Devlin
  • Joan Doppke
  • Gregory Dore
  • Mac MacDougall
  • Malinda Ellwood
  • Nkiruka Emeagwali
  • Alan Epstein
  • Barnaby Evans
  • Elena Falcone-Relvas
  • Gabriel Fernandez
  • Katie Fillion
  • Paul Fitzgerald
  • Ryan Fugate
  • Melissa Gaitanis
  • Justina Gamache
  • Leslie Gardner
  • Tarsha Geoghegan
  • Elenita Goris
  • Christine Goulette
  • Camilla Suzanne Graham
  • Jason Grebely
  • Rabbi Leslie Gutterman
  • Sue Hart
  • Stephen Hartley
  • Claire Haynes
  • Jennifer Hoffer
  • Scott Holmberg
  • Melanie Holmberg
  • Karen Isselbacher
  • Marjorie Janvier
  • Breanne Johnson
  • Jeff Johnson
  • Laura E. Johnson
  • Betsy Jones
  • Raynald Joseph
  • Brett D. Kalmowitz
  • Susan Kaplan
  • Patricia Kaplan Bowen
  • David Katzevich
  • Paul Kelly
  • Jag Khalsa
  • Arthur Kim
  • Janet Korins
  • Mary Korr
  • Kenneth Korr
  • Elsa Larson
  • Tammy Lederer
  • Angela Lemire
  • Jules Levin
  • Jason Levine
  • Benjamin Linas
  • Liquor Wicks Candles
  • Paul Loberti
  • Manuel Lopez
  • Oz Lugo
  • Mario Luis
  • William Lyman
  • Cindy MacLeod
  • Brandon Marshall
  • Paula Martesian
  • Mikayla Mcadams
  • Keith McManus
  • Tom McQuaid
  • Jen McWeeney
  • Roberta Meglio
  • Peter Mello
  • Brandie Millovitsch
  • Brian Montague
  • Amanda Noska
  • Amy Nunn
  • Steven Peligian
  • Megan Pinkston
  • Diane Plante
  • Joe Reddish
  • Saidi Reza
  • Rhode Island Organ Donor Awareness Coalition (RIODAC)
  • RI Blood Center
  • Lou Rice
  • Josiah Rich
  • Laryl Riley
  • Andrea Ritter
  • Mike Rizzi
  • Joanne Rodgers
  • Heather Ross
  • Lorren Sandts
  • Ginna Schiapo
  • Samir Shah
  • Edwin Silva
  • John A. Simonetti
  • Sophie Sprecht-Walsh
  • Janet Steig
  • Neil Steinberg
  • Tracy Swan
  • Karen Tashima
  • Judith Taylor
  • Arnold Taylor
  • Aila TaylorBally
  • Etai Taylor Bally
  • Patricia Threats
  • Caitlin Towey
  • Judith Tsui
  • Sheila Tumilty
  • University Medicine
  • Corey Ventetuolo
  • Fred Vohr
  • Darren Wells
  • Ivan Wolfson
  • Lola Wright
  • Ali Zaman
  • Daniel Zariczny
  • Yidan Zeng
  • Brett Schneider
  • David Comer
  • Charles Fagundes
  • Amy Rasmussen
  • Naomi Adjei
  • Angelica Meinhofer
  • Christoph Schorl
  • Alex Reda
  • Julia Harvey
  • Nell Baldwin
  • Chloe Day
  • Alicia Lu
  • Katie Baird
  • Meredith Wasserman
  • Rebecca Bracken
  • Katherine Taylor
  • Rebecca Slotkin
  • Jing Wang
  • Soumitri Barua
  • Nathaniel Nelson
  • Kevin Simmons
  • Michelle Koh